155 related articles for article (PubMed ID: 10515755)
1. Liposomal amphotericin B for fever and neutropenia.
Winston DJ; Schiller GJ; Territo MC
N Engl J Med; 1999 Oct; 341(15):1154-5. PubMed ID: 10515755
[No Abstract] [Full Text] [Related]
2. Liposomal amphotericin B for fever and neutropenia.
Rakita R
N Engl J Med; 1999 Oct; 341(15):1153-4; author reply 1154-5. PubMed ID: 10515754
[No Abstract] [Full Text] [Related]
3. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
Walsh TJ; Finberg RW; Arndt C; Hiemenz J; Schwartz C; Bodensteiner D; Pappas P; Seibel N; Greenberg RN; Dummer S; Schuster M; Holcenberg JS
N Engl J Med; 1999 Mar; 340(10):764-71. PubMed ID: 10072411
[TBL] [Abstract][Full Text] [Related]
4. Liposomal amphotericin B for fever and neutropenia.
Wingard JR
N Engl J Med; 1999 Oct; 341(15):1153; author reply 1154-5. PubMed ID: 10515753
[No Abstract] [Full Text] [Related]
5. Liposomal amphotericin B for fever and neutropenia.
Prentice HG; Kibbler CC
N Engl J Med; 1999 Oct; 341(15):1152-3; author reply 1154-5. PubMed ID: 10515751
[No Abstract] [Full Text] [Related]
6. Liposomal amphotericin B for fever and neutropenia.
Fischer T; Heussel G; Huber C
N Engl J Med; 1999 Oct; 341(15):1152; author reply 1154-5. PubMed ID: 10515750
[No Abstract] [Full Text] [Related]
7. Lipid formulations of amphotericin B.
Dix SP; Andriole VT
Curr Clin Top Infect Dis; 2000; 20():1-23. PubMed ID: 10943516
[TBL] [Abstract][Full Text] [Related]
8. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia.
Noel GJ
J Pediatr; 1999 Sep; 135(3):399. PubMed ID: 10523149
[No Abstract] [Full Text] [Related]
9. A benefit for renal function after early switch to liposomal amphotericin B from conventional formulation in empirical antifungal treatment.
Isnard F; Tilleul P; Laporte JP; Chevallier P; Pigneux A; Lafuma A; Mahi L; Deray G
Nephrol Dial Transplant; 2007 Oct; 22(10):3090-1. PubMed ID: 17595189
[No Abstract] [Full Text] [Related]
10. Cost-effective use of liposomal amphotericin B.
O'Connell B; Craig JI; Marcus RE; Ludlam H
Clin Lab Haematol; 2002 Oct; 24(5):317-9. PubMed ID: 12358895
[No Abstract] [Full Text] [Related]
11. Liposomal amphotericin B indicated for empirical therapy.
AIDS Patient Care STDS; 1997 Dec; 11(6):458-9. PubMed ID: 11361874
[No Abstract] [Full Text] [Related]
12. Empirical antifungal therapy for persistent fever in patients with neutropenia.
Chandrasekar PH
Clin Infect Dis; 2001 Jan; 32(2):320-1. PubMed ID: 11170928
[No Abstract] [Full Text] [Related]
13. Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
Ullmann AJ; Heussel CP; Cornely OA
N Engl J Med; 2002 May; 346(22):1745-7; author reply 1745-7. PubMed ID: 12041526
[No Abstract] [Full Text] [Related]
14. Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever.
Powers JH; Dixon CA; Goldberger MJ
N Engl J Med; 2002 Jan; 346(4):289-90. PubMed ID: 11807157
[No Abstract] [Full Text] [Related]
15. Pharmacoeconomic analysis of caspofungin versus liposomal amphotericin B as empirical antifungal therapy for neutropenic fever.
Wingard JR; Leather HL; Wood CA; Gerth WC; Lupinacci RJ; Berger ML; Mansley EC
Am J Health Syst Pharm; 2007 Mar; 64(6):637-43. PubMed ID: 17353573
[TBL] [Abstract][Full Text] [Related]
16. Use of liposomal amphotericin B in bone marrow transplant.
Sastry PS; Parikh PM; Kulkarni PS; Bhagwat R; Gadade H
J Postgrad Med; 2005; 51 Suppl 1():S49-52. PubMed ID: 16519256
[TBL] [Abstract][Full Text] [Related]
17. Pharmacoeconomics of antifungal therapy.
Cooke J
Bone Marrow Transplant; 1994; 14 Suppl 5():S18-20. PubMed ID: 7703927
[No Abstract] [Full Text] [Related]
18. Liposomal amphotericin B for the treatment of severe fungal infection.
Michaud D
Dynamics; 2001; 12(1):17-21. PubMed ID: 11982230
[TBL] [Abstract][Full Text] [Related]
19. Caspofungin versus liposomal amphotericin B for empirical therapy.
Schneemann M; Imhof A
N Engl J Med; 2005 Jan; 352(4):410-4; author reply 410-4. PubMed ID: 15675094
[No Abstract] [Full Text] [Related]
20. A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group.
Wingard JR; White MH; Anaissie E; Raffalli J; Goodman J; Arrieta A;
Clin Infect Dis; 2000 Nov; 31(5):1155-63. PubMed ID: 11073745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
